Schedule 13D ownership disclosure

Immix Biopharma, Inc.

Security class unavailable · CUSIP: 45258H106

Event date: 2023-08-21

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
3,255,734
Percent of class
19.9900%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001068238-23-000182
Form type
SC 13D
Filer
GKCC, LLC
CIK
CIK 1977769
Filed
Aug 30, 2023
Reporting period
Aug 21, 2023
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub